References
- Bussing A. Mistletoe: A story with an open end. Anticancer Drugs 8: S1-S2 (1997) https://doi.org/10.1097/00001813-199704001-00001
- Rentea R, Lyon E, Hunter R. Biologic properties of iscador: A Viscum album preparation I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following X-irradiation. Lab. Invest. 44: 43-48 (1981)
-
Yoon TJ, Yoo YC, Hong EK, Cho YH, Lee SW, Yoo BL, Kim JB. Effect of Korean mistletoe extracts on the induction of IL-1
$\beta$ and TNF-$\alpha$ from mouse macrophages. Korean J. Pharmacogn. 25: 132-139 (1994) - Khwaja TA, Dias CB, Pentecost S. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 43 (Suppl. 1): 42-50 (1986)
- Blocksma N, Dijk HV, Korst P, Willers JM. Cellular and humoral adjuvant activity of mistletoe extract. Immunology 156: 309-319 (1979)
- Park WB, Kim HS. Changes of lectin from Viscum coloratum by fermentation with Lactobacillus plantarum-isolation and purification. Yakhak Hoeji 38: 418-424 (1994)
- Yoon TJ, Yoo YC, Kang TB, Shimazaki KI, Song SK, Lee KH, Kim SH, Park CH, Azuma I, Kim JB. Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells. Cancer Lett. 136: 33-40 (1999) https://doi.org/10.1016/S0304-3835(98)00300-0
- Yoon TJ, Yoo YC, Kang TB. Baek YJ, Huh CS, Song SK, Lee KH, Azuma I, Kim JB. Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity. Int. J. Immunopharmaco. 20: 163-172 (1998) https://doi.org/10.1016/S0192-0561(98)00024-1
- Yoon TJ, Yoo YC, Choi OB, Do MS, Kang TB, Lee SW, Azuma I, Kim JB. Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumor angiogenesis and metastasis of haematogenous and non-haematogeneous tumor cells in mice. Cancer Lett. 97: 83-91 (1995) https://doi.org/10.1016/0304-3835(95)03956-W
- Gabius S, Joshi SS, Kayser K, Gabius HJ. The galactoside-specific lectin from mistletoe as biological response modifier. Int. J. Oncol. 1: 705-708 (1998)
-
Hajto T, Hostanska K, Rordorf C, Gabius HJ. Increased secretion of tumor necrosis factor-
$\alpha$ , interleukin 1, and interleukin 6 by human mononuclear cells exposed to$\beta$ -galactoside lectin from clinically applied mistletoe extract. Cancer Res. 50: 3322-3326 (1990) - Endo Y, Tsurugi K, Franz H. The site of action of the A-chain of mistletoe lectin I on eucaryotic ribosomes-the RNA N-glycosidase activity of the protein. FEBS Lett. 231: 378-380 (1988) https://doi.org/10.1016/0014-5793(88)80853-6
- Lyu SY, Choi SH, Park WB. Korean mistletoe lectin induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch. Pharm. Res. 25: 93-101 (2002) https://doi.org/10.1007/BF02975269
-
Hajto T, Hostanska K, Gabius HJ. Modulatory potency of the
$\beta$ - galactoside specific lectin from mistletoe extract (Iscador) on the host defense system in vitro, in rabbits and patients. Cancer Res. 49: 4803-4808 (1989) - Gilles RG, Jung ML, Dominique DS, Beck JP. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells. Oncology 43 (suppl. 1): 35-41 (1986)
- Hajto T. Immunomodulatory effects of Iscador: A Viscum album preparation. Oncology 43 (suppl. 1): 51-65 (1986)
- Holtskog R, Sand K, Olsnes S. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties. Oncology 45: 172-179 (1988) https://doi.org/10.1159/000226557
- Yoon TJ, Yoo YC, Kang TB, Song SK, Lee KB, Her E, Song KS, Kim JB. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells. Arch. Pharm. Res. 26: 861-867 (2003) https://doi.org/10.1007/BF02980033
- Yoon TJ, Yoo YC, Kang TB, Kim SH, Kim KS, Kim JB. Production of monoclonal antibodies specific to Korean mistletoe lectin(KML-C) and their characterization. Yakhak Hoeji 45: 180-189 (2001)
- Yoon TJ, Yoo YC, Kang TB, Song SK, Do MS, Kim JB. Immunoadjuvant activitiy of Korean mistletoe extract (Viscum album coloratum) to enhance humoral and cellular immune response. Korean J. Immunol. 21: 63-70 (1999)
- Yoon TJ, Yoo YC, Kang TB, Lee KH, Kwak JH, Baek YJ, Huh CS, Kim JB. Fermented extracts of Korean mistletoe with Lactobacillus (FKM-110) stimulate macrophage and inhibit tumor metastasis. Korean J. Food Sci. Technol. 31: 838-847 (1999)
- Kang TB, Yoon TJ, Kim JB, Song SK, Lee KH, Kwak JH. Preliminary toxocity and general pharmacology of KML-IIU, a purified lectin from Korean mistletoe (Viscum album coloratum). Yakhak Hoeji 45: 251-257 (2001)
- Andreesen R, Scheibenbogen C, Brugger W, Krause S, Meerpohl HG, Leser HG, Engler H, Lohr GW. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating monocytes: A new approach to cancer immunotherapy. Cancer Res. 50: 7450-7456 (1990)
- Hawiger J. Innate immunity and inflammation: A transcriptional paradigm. Immunol. Res. 23: 99-109 (2001) https://doi.org/10.1385/IR:23:2-3:099
- Sato K, Yoo YC, Fukushima A, Saiki I, Takahashi TA, Fujihara M, Tono-Oka S, Azuma I. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia. Infect. Immun. 63: 2859-2866 (1995)
- Mueller EA, Hamprecht K, Anderer FA. Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity. Immunopharmacology 17: 11-18 (1989) https://doi.org/10.1016/0162-3109(89)90003-9
- Kang TB, Chae DJ, Chang SH, Mun SH, Kim JB, Her E. The effect of Korean mistletoe extract M11C (non-lectin components) on TNF-a release and expression from macrophage. Korean J. Immunol. 22: 207-215 (2000)
- ZarkoviN, Kalisnik T, LoncariI, BoroviS, Mang S, Kissel D, Konitzer M, Jurin M, Grainza S. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10. Cancer Biother. Radio. 13: 121-131 (1998) https://doi.org/10.1089/cbr.1998.13.121
- Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi, N. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18: 833-841 (1997) https://doi.org/10.1093/carcin/18.4.833
- Kim Y, Lee D, Kim D, Cho J, Yang J, Chung M, Kim K, Ha N. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch. Pharm. Res. 31: 468-473 (2008) https://doi.org/10.1007/s12272-001-1180-y
- Ataie-Jafari A, Larijani B, Alavi-Majd H, Tahbaz F. Cholesterollowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab. 54: 22-27 (2009) https://doi.org/10.1159/000203284